{"id":"W4401036743","doi":"10.1111/bcp.16188","title":"Model‐based population pharmacokinetic and exposure response analyses for safety and efficacy of nivolumab as adjuvant treatment in subjects with resected oesophageal or gastroesophageal junction cancer","year":2024,"lang":"en","type":"article","venue":"British Journal of Clinical Pharmacology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada","keywords":"Nivolumab; Medicine; Adjuvant; Gastroesophageal Junction; Regimen; Oncology; Internal medicine; Clinical trial; Population; Dosing; Cancer; Pharmacology; Immunotherapy; Adenocarcinoma","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01072538,0.0008930537,0.001263903,0.0005279281,0.0001674323,0.0008460266,0.0007554654,0.0005947148,0.002013062],"category_scores_gemma":[0.00749061,0.0003791353,0.003334676,0.0003514691,0.0002779059,0.0003966194,0.000517595,0.001167516,0.0002705016],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000676534,"about_ca_system_score_gemma":0.0009004368,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002470025,"about_ca_topic_score_gemma":0.001342945,"domain_scores_codex":[0.9974438,0.00192588,0.00006446413,0.0003362796,0.0001334999,0.00009608728],"domain_scores_gemma":[0.9922553,0.006087282,0.0008496509,0.0004971492,0.0002040069,0.0001065631],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.03977194,0.001879365,0.2777506,0.0007564428,0.02139372,0.0005234656,0.0002630648,0.595277,0.01038694,0.002507293,0.002486138,0.04700404],"study_design_scores_gemma":[0.001410031,0.01095573,0.1179347,0.00005118339,0.005968493,0.0004706136,0.00009569011,0.8540062,0.003395562,0.003172135,0.002453067,0.00008657026],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9713122,0.001331531,0.02396954,0.0002019981,0.00002349024,0.0002429396,0.001658326,0.0001722505,0.001087594],"genre_scores_gemma":[0.9950125,0.0002135979,0.002825506,0.0000841219,0.00001227187,0.0001312252,0.00119264,0.00001601116,0.0005121775],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01072538,"threshold_uncertainty_score":0.05672193,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07829050037331493,"score_gpt":0.4593845543687192,"score_spread":0.3810940539954042,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}